Advanced search
Publication Cover
International Journal of Cardiovascular Interventions Volume 4, 2001 - Issue 2
Journal homepage
24
Views
1
CrossRef citations to date
0
Altmetric
Research Article

An introduction to provisional stenting

Carlo Di Mario IRCCS Ospedale 'San Raffaele', Milan, Italy
&
Nico HJ Pijls Catharina Hospital, Eindhoven, The Netherlands
Pages 59-65 | Published online: 10 Jul 2009

  • Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 1987; 316: 701-706.
  • Roubin GS, Cannon AD, Agraval SK et al. Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation 1992; 85:916-927.
  • Serruys PW, Juilliere Y, Bertrand ME, Puel J, Rickards AF, Sigwart U. Additional improvement of stenosis geometry in human coronary arteries by stenting after balloon dilatation. Am J Cardiol 1988; 61: 71G-76G.
  • Haude M, Erbel R, Straub U, Dietz U, Meyer J. Short and long term results after intracoronary stenting in human coronary arteries: monocentre experience with the balloon- expandable Palmaz-Schatz stent. Br Heart J 1991; 66: 337-345.
  • Schatz RA, Baim DS, Leon M et al. Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study. Circulation 1991; 83: 148-161.
  • Kuntz RE, Gibson CM, Nobuyoshi M, Baim DS. Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. J Am Coll Cardiol 1993; 21: 15-25.
  • Kuntz RE, Keaney KM, Senerchia C, Baim DS. A predictive method for estimating the late angiographie results of coronary intervention despite incomplete ascertainment. Circulation 1993; 87: 815-830.
  • Karrillon GJ, Morice MC, Benveniste et al. lntracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy. 30-day clinical outcome of the French Multicenter Registry. Circulation 1996; 94: 1519-1527.
  • Colombo A, Hall P, Nakamura S et al. lntracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995; 91: 1676-1688.
  • Barragan P, Sainsous J, Sivestri M et al. Ticlopidine and subcutaneous heparin as an alternative regimen following coronary stenting. Cathet Cardiovasc Diagn 1994; 32: 133-138.
  • Serruys PW, Di Mario C. Who was thrombogenic: the stent or the doctor? Circulation 1995; 91: 1891-1893.
  • Serruys PW, De Jaegere P, Kiemeneij F et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994; 331: 489-495.
  • Fischman DL, Leon MB, Baim DS et al. A randomized comparison of coronaiy-stent placement and balloon angioplasty in the treatment of coronary arteiy disease. Stent Restenosis Study Investigators. N Engl J Med 1994; 331: 496-501.
  • Serruys PW, Emanuelsson H, Van der Giessen W et al. Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II Pilot Study. Circulation. 1996; 93: 412-422.
  • Serruys P, Kutryk M. Handbook of Coronaiy Stents, third edn. London: Martin Dunitz, 2000.
  • Calver AL, Dawkins KD, Gray HH, Simpson IA, Haywood GA, Morgan JM. lntracoronary Multi-link stents: experience in 218 patients using aspirin alone. Heart 1998; 80: 499-504.
  • Almagor Y, Feld S, Kiemeneij F et al. First international new intravascular rigid-flex endovascular stent study (FlNESS): clinical and angiographie results after elective and urgent stent implantation. The FlNESS Trial Investigators. J Am Coll Cardiol 1997; 30: 847-854.
  • Roguin A, Grenadier E, Peled B, Markiewicz W, Beyar R. Acute and 30-day results of the serpentine balloon expandable stent implantation in simple and complex coronary arterial narrowings. Am J Cardiol 1997; 80: 1155-1162.
  • Schalij MJ, Savalle LH, Tresukosol D, Jukema JW, Reiber JH, Bruschke AV. Micro stent I, initial results, and six months follow-up by quantitative coronary angiography. Cathet Cardiovasc Diagn 1998; 43: 19-27.
  • Haase J, Geimer M, Gohring S. Results of micro stent implantations in coronary lesions of various complexity. Am J Cardiol 1997; 80: 1601-1602.
  • Kastrati A, Dirschinger J, Boekstegers P et al. Influence of stent design on 1-year outcome after coronary stent placement: a randomized comparison of five stent types in 1147 unselected patients. Cathet Cardiovasc Intervent 2000; 50: 290-297.
  • Di Mario C, Reimers B, Reinhardt R, Ferraro M, Moussa I, Colombo A. New stent delivery balloon: a technical note. Cathet Cardiovasc Diagn 1997; 42: 452-456.
  • Akiyama T, Moussa l, Reimers B et al. Angiographie and clinical outcome following coronary stenting of small vessels: a comparison with coronary stenting of large vessels. J Am Coll Cardiol 1998; 32: 1610-1618.
  • Elezi S, Kastrati A, Neumann FJ, Hadamitzky M, Dirschinger J, Schomig A. Vessel size and long-term outcome after coronary stent placement. Circulation 1998; 98: 1875-1880.
  • Mehran R, Dangas G, Abizaid AS et al. Angiographie patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 1999; 100: 1872-1878.
  • De Feyter PJ, Kay P, Disco C, Serruys PW. Reference chart derived from post-stent-implantation intravascular ultrasound predictors of 6-month expected restenosis on quantitative coronary angiography. Circulation 1999; 100: 1777-1783.
  • Finci L, Ferraro M, Nishida T et al. Coronary stenting beyond standard indications. Immediate and follow-up results, ltal Heart) 2000; 1: 739-748.
  • Kasaoka S, Tobis JM, Akiyama T et al. Angiographie and intravascular ultrasound predictors of in-stent restenosis. J Am Coll Cardiol 1998; 32: 1630-1635.
  • The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein Ilb/IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation. N Engl J Med 1994; 330: 956-961.
  • The EPILOG Investigators. Platelet glycoprotein Ilb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997; 336: 1689-1696.
  • The CAPTURE Investigators. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study. Lancet 1997; 349 (9063): 1429-1435.
  • Goldberg RK, Kleiman NS, Minor ST, Abukhalil J, Raizner AE. Comparison of quantitative coronary angiography to visual estimates of lesion severity pre and post PTCA. Am Heart) 1990; 119: 178-184.
  • Keane D, Haase J, Slager CJ et al. Comparative validation of quantitative coronary angiography systems. Results and implications from a multicenter study using a standardized approach. Circulation 1995; 91: 2174-2183.
  • Di Mario C, Haase J, Den Boer A, Reiber JH, Senaiys PW. Edge detection versus densitometry in the quantitative assessment of stenosis phantoms: an in vivo comparison in porcine coronary arteries. Am Heart J 1992; 124: 1181-1189.
  • Doucette JW, Kimura A, Hiramatsu O et al. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation 1992; 85: 1899-1911.
  • Serruys PW, Di Mario C, Meneveau N et al. Intracoronary pressure and flow velocity with sensor-tip guidewires: a new methodologie approach for assessment of coronary hemodynamics before and after coronary interventions. Am J Cardiol 1993; 71: 41D-53D.
  • Kern MJ, Donohue TJ, Bach RG, Aguirre FV, Caracciolo EA, Ofili EO. Quantitating coronary collateral flow velocity in patients during coronary angioplasty using a Doppler guidewire. Am J Cardiol 1993; 71: 34D-40D.
  • Ofili EO, Kern MJ, Labovitz AJ et al. Analysis of coronary blood flow velocity dynamics in angiographically normal and stenosed arteries before and after endolumen enlargement by angioplasty. J Am Coll Cardiol 1993; 21: 308-316.
  • Baumgart D, Haude M, Goerge G et al. Improved assessment of coronary stenosis severity using the relative flow velocity reserve. Circulation 1998; 98: 40-46.
  • Serruys PW, Di Mario C, Piek J et al. Prognostic value of intracoronary flow velocity and diameter stenosis in assessing the short- and long-term outcomes of coronary balloon angioplasty: the DEBATE Study (Doppler Endpoints Balloon Angioplasty Trial Europe). Circulation 1997; 96: 3369-3377.
  • Serruys PW, De Bruyne B, Carlier S et al. Randomized comparison of primary stenting and provisional balloon angioplasty guided by flow velocity measurement Circulation 2000; 102: 2930-2937.
  • Di Mario C, Moses JW, Anderson TJ et al. Randomized comparison of elective stent implantation and coronary balloon angioplasty guided by online quantitative angiography and intracoronary doppler. Circulation 2000; 102: 2938-2944.
  • Lafont A, Dubois-Rande JE, Steg PC et al. The French Randomized Optimal Stenting Trial: a prospective evaluation of provisional stenting guided by coronary velocity reserve and quantitative coronary angiography. FROST Study Group. J Am Coll Cardiol 2000; 36: 404-409.
  • Cohen D, Di Mario M, Moses J et al. In-hospital and 6 month follow-up costs of universal vs provisional stenting: results from the DESTlNl trial. Circulation 1998; 98: 1-499.
  • Cantor WJ, Peterson ED, Popma JJ. Provisional stenting strategies: systematic overview and implications for clinical decision-making. J Am Coll Cardiol 2000; 36: 1142-1151.
  • Anderson HV, Carabello BA. Provisional versus routine stenting: routine stenting is here to stay. Circulation 2000; 102:2910-2914.
  • Briguori C, Sheiban 1, De Gregorio J et al. Direct coronary stenting without predilation. J Am Coll Cardiol 1999; 34: 1910-1915.
  • Pijls NH, Van Gelder B, Van Der Voort P et al. Fractional flow reserve. A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation 1995; 92: 3183-3193.
  • Segers P, Postier G, Neckebroeck J, Verdonck P. Assessing coronary artery stenosis severity: in vitro validation of the concept of fractional flow reserve. Cathet Cardiovasc Intervent 1999; 46: 375-379.
  • Pijls NH, Van Son JA, Kirkeeide RE, De Bruyne B, Could KE. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation 1993; 87: 1354-1367.
  • De Bruyne B, Baudhuin T, Melin JA. Coronary flow reseive calculated from pressure measurements in humans. Validation with positron emission tomography. Circulation 1994; 89: 1013-1022.
  • De Bruyne B, Bartunek J, Sys SU, Heyndrickx GR. Relation between myocardial fractional flow reserve calculated from coronary pressure measurements and exercise-induced myocardial ischemia. Circulation 1995; 92: 39-46.
  • Bartunek J, Marwick TH, Rodrigues AC et al. Dobutamineinduced wall motion abnormalities: correlations with myocardial fractional flow reserve and quantitative coronary angiography. J Am Coll Cardiol 1996; 27: 1429-1436.
  • Pijls NH, De Bruyne B, Peels K et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 1996; 334: 1703-1708.
  • Rodriguez A, Ayala F, Bernardi V et al. Optimal coronary balloon angioplasty with provisional stenting versus primaiy stent (OCBAS): immediate and long-term follow-up results. J Am Coll Cardiol 1998; 32: 1351-1357.
  • Weaver WD, Reisman MA, Griffin JJ et al. Optimum percutaneous transluminal coronary angioplasty compared with routine stent strategy trial (OPUS-1): a randomised trial. Lancet 2000; 355 (9222): 2199-2203.
  • Haase KK, Athanasiadis A, Mahrholdt H et al. Acute and one year follow-up results after vessel size adapted PTCA using intracoronary ultrasound. Eur Heart J 1998; 19: 263-272.
  • Abizaid A, Pichard AD, Mintz GS et al. Acute and long-term results of an intravascular ultrasound-guided percutaneous transluminal coronary angioplasty/provisional stent implantation strategy. Am J Cardiol 1999; 84: 1298-1303.
  • Bech GJ, Pijls NH, De Bruyne B. Usefulness of fractional flow reserve to predict clinical outcome after balloon angioplasty. Circulation 1999; 99: 883-888.
  • Sheiban I, Albiero R, Marsico F et al. Immediate and longterm results of T stenting for bifurcation coronary lesions. AmJ Cardiol 2000; 85: 1141-1144.
  • Yamashita T, Nishida T, Adamian MG et al. Bifurcation lesions: two stents versus one stent -- immediate and followup results. J Am Coll Cardiol 2000; 35: 1145-1151.
  • Moussa 1, De Gregorio J, Di Mario C, Colombo A. The use of intravascular ultrasound and spot stenting for the treatment of long lesions and small vessels. J Invas Cardiol 1999; 11: 47-55.
  • Schroeder S, Baumbach A, Marholdt M et al. The impact of untreated coronary dissections on acute and long-term outcome after intravascular ultrasound guided PTCA. Eur Heart J 2000; 21: 137-145.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.